Mostrando 2 resultados de: 2
Filtros aplicados
Towards a paradigm shift in the treatment of chronic chagas disease
ReviewAbstract: Treatment for Chagas disease with currently available medications is recommended universally only foPalabras claves:Autores:Araujo-Jorge T., de Noya B.A., Gascón J., Guhl F., López M.C., Mario J. Grijalva, Ramsey J.M., Ribeiro I., Schijman A.G., Sosa-Estani S., Torrico F., Viotti R.Fuentes:scopusSerological reactivity against T. cruzi-derived antigens: Evaluation of their suitability for the assessment of response to treatment in chronic Chagas disease.
ArticleAbstract: Chagas disease, caused by the protozoan Trypanosoma cruzi, affects more than 6 million people worldwPalabras claves:3973, antigens, Chagas disease, Chemotherapy response, Chronic infection, F29, hsp70, InfYnity multiplexed ELISA, KMP11, PFR2, TRYPANOSOMA CRUZIAutores:Abril M., Alonso-Padillaid J., Benítez C., Casellas A., Chatelain E., de Noya B.A., Esteva M., Gascón J., Gómez I., Granjon E., Guhl F., Hasslochermoreno A.M., Jorge T.A., Longhi S.A., López M.C., Luquetti A.O., Mario J. Grijalva, Méndez S., Noya O., Pinazo M.J., Ramsey J.M., Ribeiro I., Ruiz A.M., Sanz S., Schijman A.G., Sosa-Estani S., Thomas M.C., Torrico F., Viotti R., Zrein M.Fuentes:scopus